Header Logo

Stacey Honda

Concepts (199)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Lung Neoplasms
11
2025
260
1.780
Why?
Early Detection of Cancer
13
2025
513
1.090
Why?
Microbiota
1
2022
4
0.810
Why?
Multiple Myeloma
2
2014
9
0.800
Why?
Colorectal Neoplasms
4
2022
616
0.790
Why?
Adenoma
1
2022
94
0.730
Why?
Skin Neoplasms
3
2024
57
0.610
Why?
Humans
37
2025
17707
0.510
Why?
Proteostasis Deficiencies
1
2014
1
0.460
Why?
Amyloidosis
1
2014
3
0.460
Why?
Mass Screening
5
2025
667
0.380
Why?
Male
17
2025
10094
0.380
Why?
Quality Improvement
2
2024
189
0.360
Why?
Immunoglobulin D
1
2010
1
0.350
Why?
Multiple Trauma
1
2010
2
0.350
Why?
Rib Fractures
1
2010
2
0.350
Why?
Neoplasms
3
2022
442
0.340
Why?
Mycobacterium Infections, Nontuberculous
2
2022
12
0.330
Why?
Biomarkers, Tumor
3
2021
144
0.330
Why?
Aged
15
2025
6150
0.330
Why?
MicroRNAs
2
2021
16
0.320
Why?
Electronic Health Records
4
2023
694
0.320
Why?
Carcinoma, Ductal, Breast
2
2021
53
0.320
Why?
Heart Failure
1
2014
398
0.310
Why?
Middle Aged
18
2025
7976
0.310
Why?
Female
19
2025
12729
0.300
Why?
United States
11
2025
3914
0.260
Why?
Tomography, X-Ray Computed
5
2025
211
0.240
Why?
Skin Diseases, Papulosquamous
1
2005
1
0.240
Why?
CD56 Antigen
1
2005
1
0.240
Why?
Killer Cells, Natural
1
2005
3
0.240
Why?
CD4 Antigens
1
2005
2
0.240
Why?
Exanthema
1
2005
7
0.240
Why?
Lymphoma, T-Cell, Cutaneous
1
2005
4
0.240
Why?
Health Services Research
2
2016
213
0.240
Why?
Delivery of Health Care
5
2019
397
0.230
Why?
Occult Blood
2
2022
154
0.220
Why?
Guideline Adherence
1
2025
155
0.220
Why?
ras Proteins
2
2014
20
0.220
Why?
Proto-Oncogene Proteins
2
2014
32
0.210
Why?
Melanoma
1
2024
35
0.210
Why?
Deductibles and Coinsurance
1
2023
30
0.210
Why?
Patient Compliance
1
2025
299
0.200
Why?
RNA, Ribosomal, 16S
1
2022
4
0.200
Why?
Carcinoma, Non-Small-Cell Lung
1
2023
50
0.200
Why?
Prepaid Health Plans
1
2022
19
0.200
Why?
Opportunistic Infections
1
2022
7
0.200
Why?
Adult
10
2024
7658
0.200
Why?
Myxoma
1
2002
1
0.200
Why?
Skin Pigmentation
1
2002
6
0.200
Why?
Testicular Neoplasms
1
2002
11
0.200
Why?
Biological Specimen Banks
1
2022
11
0.190
Why?
Population Surveillance
1
2024
265
0.190
Why?
Neoplasms, Multiple Primary
1
2002
18
0.190
Why?
Feces
1
2022
80
0.190
Why?
Population Dynamics
1
2021
6
0.190
Why?
Breast Neoplasms
2
2021
956
0.190
Why?
Preventive Medicine
1
2021
24
0.190
Why?
Carcinoma, Intraductal, Noninfiltrating
1
2021
41
0.190
Why?
Aged, 80 and over
7
2025
1927
0.180
Why?
Transfusion-Related Acute Lung Injury
1
2021
1
0.180
Why?
Transfusion Reaction
1
2021
2
0.180
Why?
Blood Transfusion
1
2021
3
0.180
Why?
Respiratory Insufficiency
1
2021
17
0.180
Why?
Cancer Survivors
1
2022
91
0.180
Why?
Colonoscopy
1
2022
253
0.170
Why?
Retrospective Studies
6
2025
2471
0.170
Why?
Models, Organizational
1
2019
54
0.160
Why?
Neoplasm Recurrence, Local
2
2025
247
0.160
Why?
Prospective Studies
1
2022
1287
0.150
Why?
Genetic Testing
3
2014
74
0.150
Why?
Lung
3
2024
62
0.150
Why?
Cohort Studies
5
2022
2589
0.140
Why?
Gene Library
1
2017
3
0.140
Why?
Paraffin Embedding
1
2017
5
0.140
Why?
Sequence Analysis, DNA
1
2017
30
0.140
Why?
ErbB Receptors
2
2016
5
0.140
Why?
Tuberculosis
1
2017
23
0.130
Why?
Serum Albumin
2
2009
4
0.130
Why?
Mixed Tumor, Malignant
1
2016
1
0.130
Why?
Mixed Tumor, Mullerian
1
2016
1
0.130
Why?
Neoplasms, Cystic, Mucinous, and Serous
1
2016
1
0.130
Why?
Heparin-binding EGF-like Growth Factor
1
2016
1
0.130
Why?
Cell Movement
1
2016
5
0.130
Why?
Uterine Neoplasms
1
2016
14
0.130
Why?
Angiostrongylus cantonensis
1
2015
1
0.130
Why?
Strongylida Infections
1
2015
1
0.130
Why?
DNA, Helminth
1
2015
1
0.130
Why?
Meningitis
1
2015
3
0.130
Why?
Eosinophilia
1
2015
2
0.130
Why?
Real-Time Polymerase Chain Reaction
1
2015
12
0.130
Why?
Adolescent
6
2022
3671
0.120
Why?
Smoking
3
2023
483
0.120
Why?
Pragmatic Clinical Trials as Topic
1
2015
61
0.120
Why?
Glomus Jugulare
1
2013
1
0.110
Why?
Glomus Jugulare Tumor
1
2013
1
0.110
Why?
Neoplasm Staging
3
2025
331
0.110
Why?
Hawaii
3
2022
43
0.110
Why?
Colorectal Neoplasms, Hereditary Nonpolyposis
1
2013
15
0.110
Why?
Research Design
1
2015
372
0.100
Why?
Molecular Targeted Therapy
1
2012
6
0.100
Why?
Child, Preschool
3
2021
1417
0.090
Why?
Diagnosis, Differential
1
2010
60
0.090
Why?
Influenza B virus
1
2010
9
0.090
Why?
Biomarkers
2
2009
312
0.090
Why?
Influenza A virus
1
2010
13
0.090
Why?
Laboratories
1
2010
18
0.090
Why?
Disease Outbreaks
1
2010
36
0.080
Why?
Fatty Acids
1
2009
8
0.080
Why?
Myocardial Infarction
2
2009
234
0.080
Why?
Acute Coronary Syndrome
1
2009
18
0.080
Why?
Quality Assurance, Health Care
1
2010
137
0.080
Why?
National Cancer Institute (U.S.)
2
2020
16
0.080
Why?
Child
3
2021
2481
0.080
Why?
Mutation
3
2014
131
0.080
Why?
Health Status Disparities
2
2020
147
0.080
Why?
Incidence
2
2022
1269
0.080
Why?
Myocardial Ischemia
2
2009
24
0.070
Why?
Young Adult
3
2022
2450
0.070
Why?
Influenza, Human
1
2010
267
0.070
Why?
Data Collection
2
2019
252
0.060
Why?
Pilot Projects
2
2021
215
0.060
Why?
Insulinoma
1
2005
1
0.060
Why?
Practice Guidelines as Topic
2
2019
314
0.060
Why?
Infant
2
2021
1199
0.060
Why?
Recurrence
1
2025
189
0.060
Why?
Treatment Outcome
3
2016
1254
0.060
Why?
Neoplasm Metastasis
2
2014
31
0.050
Why?
Proto-Oncogene Proteins p21(ras)
2
2014
21
0.050
Why?
Immunotherapy
1
2023
6
0.050
Why?
Cobalt
1
2003
1
0.050
Why?
Pancreatic Neoplasms
1
2005
67
0.050
Why?
Nontuberculous Mycobacteria
1
2022
7
0.050
Why?
Neurilemmoma
1
2002
1
0.050
Why?
Cushing Syndrome
1
2002
2
0.050
Why?
Medicare
1
2023
199
0.050
Why?
Risk Assessment
2
2019
1106
0.050
Why?
Prognosis
2
2014
613
0.050
Why?
Community-Based Participatory Research
1
2021
61
0.050
Why?
United States Food and Drug Administration
1
2021
34
0.050
Why?
Prevalence
1
2023
882
0.040
Why?
Respiration, Artificial
1
2021
37
0.040
Why?
International Classification of Diseases
1
2021
85
0.040
Why?
Insurance, Health
1
2022
175
0.040
Why?
Hospitals
1
2021
76
0.040
Why?
Inpatients
1
2021
81
0.040
Why?
Pandemics
1
2022
286
0.040
Why?
Community Health Planning
1
2019
18
0.040
Why?
Geography
1
2019
39
0.040
Why?
Predictive Value of Tests
1
2021
355
0.040
Why?
Liquid Biopsy
1
2019
3
0.040
Why?
Registries
1
2022
470
0.040
Why?
Molecular Diagnostic Techniques
1
2019
7
0.040
Why?
Tobacco Use Cessation
1
2019
22
0.040
Why?
Health Plan Implementation
1
2019
36
0.040
Why?
Public Health Surveillance
1
2019
42
0.040
Why?
Databases, Factual
1
2021
311
0.040
Why?
Precision Medicine
1
2019
28
0.040
Why?
Cost of Illness
1
2019
94
0.040
Why?
Research
1
2019
64
0.040
Why?
Body Mass Index
1
2023
970
0.040
Why?
Disease Management
1
2019
136
0.040
Why?
Counseling
1
2019
187
0.040
Why?
Socioeconomic Factors
1
2019
626
0.040
Why?
MCF-7 Cells
1
2017
4
0.030
Why?
Lung Diseases
1
2017
41
0.030
Why?
Protein Binding
2
2009
9
0.030
Why?
Integrin alpha5
1
2016
1
0.030
Why?
Tissue Array Analysis
1
2016
1
0.030
Why?
Immunohistochemistry
1
2016
44
0.030
Why?
Neoplasm Invasiveness
1
2016
80
0.030
Why?
Hospitalization
1
2021
805
0.030
Why?
Animals
1
2015
262
0.030
Why?
Cooperative Behavior
1
2015
89
0.030
Why?
Combined Modality Therapy
1
2014
146
0.030
Why?
Medical History Taking
1
2013
35
0.030
Why?
Family Health
1
2013
44
0.030
Why?
Magnetic Resonance Imaging
1
2013
107
0.030
Why?
Medical Records
1
2013
97
0.030
Why?
Drug Administration Schedule
1
2012
100
0.030
Why?
Analysis of Variance
1
2012
159
0.020
Why?
Dose-Response Relationship, Drug
1
2012
128
0.020
Why?
Antineoplastic Agents
1
2012
60
0.020
Why?
Confidence Intervals
1
2012
237
0.020
Why?
Survival Rate
1
2012
262
0.020
Why?
Multivariate Analysis
1
2012
561
0.020
Why?
DNA, Viral
1
2010
17
0.020
Why?
Residence Characteristics
1
2012
248
0.020
Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2010
27
0.020
Why?
Sentinel Surveillance
1
2010
12
0.020
Why?
Quality Control
1
2010
44
0.020
Why?
Logistic Models
1
2012
918
0.020
Why?
Sensitivity and Specificity
1
2010
304
0.020
Why?
Risk Factors
1
2014
3367
0.020
Why?
Immunoenzyme Techniques
1
2005
21
0.010
Why?
Pancreas
1
2005
14
0.010
Why?
Binding Sites
1
2003
2
0.010
Why?
Indicators and Reagents
1
2003
5
0.010
Why?
ROC Curve
1
2003
77
0.010
Why?
Concepts (199)
Explore
_
Co-Authors (15)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
-->

© 2025 Kaiser Permanente